← Back
$OCUL All transactions

OCULAR THERAPEUTIX, INC

G

$ Value

$0

Shares

50,029

Price

$0

Filed

Aug 13

Insider

Name

Dugel Pravin

Title

See Remarks

CIK

0001700917

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-12

Code

G

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,248,738

Footnotes

On April 28, 2025, the reporting person transferred 200,332 shares to his spouse for no consideration. | On June 12, 2025, the reporting person transferred 50,029 shares to his spouse for no consideration. | On August 11, 2025, the reporting person's spouse transferred 250,361 shares to the Pravin Dugel 2024 Irrevocable Trust (the "Trust") for no consideration. The reporting person is trustee of the Trust and sole beneficiary of the Trust during his lifetime. The reporting person remains the beneficial owner of the securities held by the Trust.

Filing Info

Accession No.

0001104659-25-077724

Form Type

4

Issuer CIK

0001393434

Dugel Pravin's History

Date Ticker Type Value
2026-04-09 OCUL G $0
2026-04-09 OCUL G $0
2026-02-23 OCUL $166K
2026-02-12 OCUL $1.1M
2025-11-26 OCUL G $0
2025-11-26 OCUL G $0
2025-11-24 OCUL $235K
2025-09-09 OCUL G $0
2025-09-09 OCUL G $0
2025-08-25 OCUL $259K

Other Insiders at OCUL (90d)

Insider Bought Sold Last
LINDSTROM RICHARD L MD $461K 2026-02-20
Heier Jeffrey S.
Chief Scientific Officer
$25K 2026-02-23
Dugel Pravin
See Remarks
$1.3M 2026-04-09
Notman Donald
Chief Operating Officer
$205K 2026-02-12
Kaiser Peter
Chief Development Officer
$23K 2026-02-23
Nayak Sanjay
Chief Strategy Officer
$108K 2026-02-23
Waheed Nadia
Chief Medical Officer
$98K 2026-02-20
Robinson David Wayne
Global CCO
2026-01-21